Utility of Cardiac Biomarkers in Predicting Infarct Size, Left Ventricular Function, and Clinical Outcome After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Utility of Cardiac Biomarkers in Predicting Infarct Size, Left Ventricular Function, and Clinical Outcome After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Stanley Chia, Fred Senatore, O. Christopher Raffel, Hang Lee, Frans J. Th. Wackers, Ik-Kyung Jang...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JACC. Cardiovascular interventions 2008-08, Vol.1 (4), p.415-423
Hauptverfasser:	Chia, Stanley, MD, MRCP, Senatore, Fred, MD, PhD, FACC, Raffel, O. Christopher, MB, ChB, FRACP, Lee, Hang, PhD, Wackers, Frans J. Th., MD, PhD, FACC, Jang, Ik-Kyung, MD, PhD, FACC
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged angioplasty Angioplasty, Balloon, Coronary Benzenesulfonates - therapeutic use Biomarkers - blood cardiac biomarkers Cardiovascular Cardiovascular Agents - therapeutic use Coronary Angiography Creatine Kinase, MB Form - blood Disease-Free Survival Female Humans infarct size myocardial infarction Kaplan-Meier Estimate Male Middle Aged Myocardial Infarction - blood Myocardial Infarction - diagnostic imaging Myocardial Infarction - mortality Myocardial Infarction - physiopathology Myocardial Infarction - therapy Myocardium - pathology Piperazines - therapeutic use Predictive Value of Tests Proportional Hazards Models Prospective Studies Risk Assessment Stroke Volume Time Factors Tomography, Emission-Computed, Single-Photon Treatment Outcome Troponin I - blood Troponin T - blood United States ventricular function Ventricular Function, Left
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!